• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING. Back to Search Results
Device Problem Fracture (1260)
Patient Problem Surgical procedure, additional (2564)
Event Date 11/03/2014
Event Type  Injury  
Event Description
Patient is a (b)(6) male, diabetic but healthy/active and compliant, taking a regular dose of plavix.The procedure to implant zilver ptx stents was performed on (b)(6) 2013 based on claudication.His right leg was treated with 3 zilver ptx devices and a bare zilver on the proximal end.Stent fracture of one zilver pts stent was initially reported (reference related mdr report 3001845648-2014-00244) and a further two zilver ptx stent fractures were reported as a result of re-intervention performed on the (b)(6) 2014 (reference this report and related mdr report 3001845648-2014-003299.It is reported that the stent fractures were re-aligned with viabahn stent-grafts.It was also noted during the re-intervention procedure performed on the (b)(6) 2014 that in stent re-stenosis had occurred in one zilver ptx stent.(reference mdr report 3001845648-2014-00301).This report address stent fracture noted during re-intervention performed on the (b)(6) 2014.It is currently unknown which zilver ptx stent fractured.
 
Manufacturer Narrative
The patient is doing well.The dr will most likely perform a bypass procedure in the next month or two but wanted to try stenting as a re-intervention initially.As the device is implanted in the patient it is not available for evaluation; therefore a document based investigation was carried out.To date an image review relating to this event has not been received.To complaint as confirmed based on customer testimony.As there was no rpn or lot number provided a review of the manufacturing records could not be performed.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.As per instruction for use for all zilver pts devices, stent strut fracture is noted as a potential adverse event associated with the placement of this device.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING.
Manufacturer (Section D)
COOK IRELAND LTD
limerick
EI 
Manufacturer Contact
sinead quaid, sr specialist
613344440
MDR Report Key4317529
MDR Text Key5206603
Report Number3001845648-2014-00300
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P10022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/03/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/02/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date11/03/2014
Event Location Hospital
Date Manufacturer Received11/17/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-